Literature DB >> 8563222

Profile of urinary bile acids in familial intrahepatic cholestasis with Coombs' negative haemolytic anaemia.

A Kimura1, K Ushijima, M Suzuki, M Tohma, T Inokuchi, H Kato.   

Abstract

We present two male siblings with intrahepatic cholestasis and prolonged indirect hyperbilirubinaemia. Their familial intrahepatic cholestasis syndrome was characterized by Coombs' negative haemolytic anaemia, without giant cell transformation of hepatocytes and high concentrations of serum gamma-glutamyl transpeptidase and cholesterol. By gas chromatography-mass spectrometry, we detected large amounts of 1 beta-hydroxylated bile acids, especially 1 beta,3 alpha,7 alpha,12 alpha-tetrahydroxy-5 beta-cholan-24-oic acid (25.5-67.9% of total urine bile acids) in the urine during phenobarbital therapy. However, the amount of urinary 1 beta-hydroxylated bile acids gradually decreased as the disease progressed. At the end-stage, we detected large amounts of 7 alpha,12 alpha-dihydroxy-3-oxochol-4-en-24-oic acid (19.6% of total urine bile acids). The ratio of 7 alpha,12 alpha-dihydroxy-3-oxochol-4-en-24-oic acid to cholic acid in the urine was 0.8. We conclude that in infants with end-stage liver failure, the microsomal hydroxylation of bile acids is impaired and the excretion of delta 4-3-oxo bile acids is increased.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8563222     DOI: 10.1111/j.1651-2227.1995.tb13509.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  2 in total

1.  Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis.

Authors:  Chee-Seng Lee; Akihiko Kimura; Jia-Feng Wu; Yen-Hsuan Ni; Hong-Yuan Hsu; Mei-Hwei Chang; Hiroshi Nittono; Huey-Ling Chen
Journal:  J Lipid Res       Date:  2017-01-10       Impact factor: 5.922

2.  Diagnosis of the first Japanese patient with 3-oxo-delta4-steroid 5beta-reductase deficiency by use of immunoblot analysis.

Authors:  A Kimura; K H Kondo; K I Okuda; S Higashi; M Suzuki; T Kurosawa; M Tohma; T Inoue; A Nishiyori; M Yoshino; H Kato; T Setoguchi
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.